Financial Ratios Godrej Industries Limited
Equities
GODREJIND
INE233A01035
Consumer Goods Conglomerates
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,098.30 INR | -3.18% |
|
-5.90% | -5.89% |
03/07 | Godrej Industries Limited Chemical Business Announces Capacity Expansion | CI |
03/07 | Godrej Industries' Chemicals Business Plans INR7.5 Billion Investment for Capacity Expansion | MT |
Fiscal Period: March | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.7 | 1.7 | 3.29 | 3.45 | 2.21 | |||||
Return on Total Capital | 4.73 | 2.1 | 4.06 | 4.37 | 2.99 | |||||
Return On Equity % | 7.98 | 3.43 | 7.5 | 10.38 | 4.05 | |||||
Return on Common Equity | 7.47 | 5 | 8.91 | 12.9 | 0.75 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 28.99 | 29.65 | 28.64 | 30.53 | 34.62 | |||||
SG&A Margin | 7.42 | 9.73 | 6.57 | 7.51 | 10.14 | |||||
EBITDA Margin % | 11.35 | 9.21 | 12.87 | 13.64 | 12.39 | |||||
EBITA Margin % | 9.69 | 6.77 | 11.05 | 12.17 | 10.62 | |||||
EBIT Margin % | 9.68 | 6.77 | 11.05 | 12.17 | 10.62 | |||||
Income From Continuing Operations Margin % | 5.36 | 3.92 | 6.62 | 8.03 | 3.38 | |||||
Net Income Margin % | 4.66 | 3.37 | 4.36 | 5.51 | 0.34 | |||||
Net Avail. For Common Margin % | 3.2 | 3.36 | 4.36 | 5.51 | 0.34 | |||||
Normalized Net Income Margin | 2.65 | 3.28 | 3.25 | 3.16 | -1.38 | |||||
Levered Free Cash Flow Margin | -10.26 | -28.47 | -9.25 | -17.25 | -26.35 | |||||
Unlevered Free Cash Flow Margin | -8.24 | -26.19 | -7.07 | -14.38 | -22.62 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.61 | 0.4 | 0.48 | 0.45 | 0.33 | |||||
Fixed Assets Turnover | 3.57 | 2.79 | 3.9 | 4.05 | 3.5 | |||||
Receivables Turnover (Average Receivables) | 7.7 | 5.75 | 8.26 | 9.42 | 9.63 | |||||
Inventory Turnover (Average Inventory) | 2.51 | 1.47 | 1.52 | 1.12 | 0.59 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.04 | 1.46 | 1.36 | 1.18 | 1.15 | |||||
Quick Ratio | 0.51 | 0.69 | 0.61 | 0.35 | 0.28 | |||||
Operating Cash Flow to Current Liabilities | 0.04 | -0.06 | -0.12 | -0.2 | -0.12 | |||||
Days Sales Outstanding (Average Receivables) | 47.5 | 63.52 | 44.19 | 38.75 | 38.01 | |||||
Days Outstanding Inventory (Average Inventory) | 145.92 | 248.01 | 239.49 | 324.98 | 623.41 | |||||
Average Days Payable Outstanding | 90.65 | 100.49 | 106.26 | 84.54 | 81.86 | |||||
Cash Conversion Cycle (Average Days) | 102.78 | 211.03 | 177.42 | 279.19 | 579.56 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 77.83 | 74.94 | 111.34 | 137.35 | 191.78 | |||||
Total Debt / Total Capital | 43.77 | 42.84 | 52.68 | 57.87 | 65.73 | |||||
LT Debt/Equity | 6.86 | 23.85 | 42.3 | 50.53 | 77.52 | |||||
Long-Term Debt / Total Capital | 3.86 | 13.63 | 20.01 | 21.29 | 26.57 | |||||
Total Liabilities / Total Assets | 54.33 | 53.9 | 61.58 | 67.48 | 75.44 | |||||
EBIT / Interest Expense | 2.99 | 1.85 | 3.17 | 2.65 | 1.78 | |||||
EBITDA / Interest Expense | 3.59 | 2.52 | 3.69 | 3.02 | 2.13 | |||||
(EBITDA - Capex) / Interest Expense | 2.58 | 0.47 | 2.69 | 2 | 0.99 | |||||
Total Debt / EBITDA | 5.29 | 10.96 | 7.54 | 8 | 12.95 | |||||
Net Debt / EBITDA | 3.08 | 4.59 | 4.47 | 6.13 | 10.2 | |||||
Total Debt / (EBITDA - Capex) | 7.37 | 59.32 | 10.35 | 12.06 | 27.84 | |||||
Net Debt / (EBITDA - Capex) | 4.29 | 24.87 | 6.13 | 9.25 | 21.93 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 4.91 | -15.96 | 50.31 | 17.88 | -0.52 | |||||
Gross Profit, 1 Yr. Growth % | 21.08 | -13.54 | 43.57 | 25.65 | 11.15 | |||||
EBITDA, 1 Yr. Growth % | 17.9 | -30.49 | 100.62 | 27.63 | -9.67 | |||||
EBITA, 1 Yr. Growth % | 16.3 | -39.9 | 130.14 | 29.86 | -13.2 | |||||
EBIT, 1 Yr. Growth % | 16.83 | -39.85 | 130.14 | 29.86 | -13.2 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -32.4 | -38.91 | 154.61 | 43.15 | -58.11 | |||||
Net Income, 1 Yr. Growth % | -6.34 | -39.59 | 95.36 | 49.11 | -93.85 | |||||
Normalized Net Income, 1 Yr. Growth % | -16.65 | 4.16 | 49.42 | 14.72 | -143.56 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -43.04 | -12.38 | 96.16 | 49.07 | -93.85 | |||||
Accounts Receivable, 1 Yr. Growth % | 37.11 | -8.26 | 20.14 | -9.66 | 4.38 | |||||
Inventory, 1 Yr. Growth % | -6.31 | 92.55 | 24.77 | 80.52 | 73.62 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 7.32 | 7.59 | 8.41 | 18.19 | 12.2 | |||||
Total Assets, 1 Yr. Growth % | 12.01 | 41.84 | 17.39 | 29.18 | 39.96 | |||||
Tangible Book Value, 1 Yr. Growth % | 36.62 | 35.09 | -11.38 | 13.88 | 0.11 | |||||
Common Equity, 1 Yr. Growth % | 33.14 | 30.49 | -5.65 | 12.04 | 0.21 | |||||
Cash From Operations, 1 Yr. Growth % | -68.24 | -269.28 | 161.28 | 151.08 | -2.84 | |||||
Capital Expenditures, 1 Yr. Growth % | -12.05 | 92.21 | -28.92 | 58 | 44.68 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -733.4 | 117.44 | -51.2 | 129.5 | 51.94 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -322.11 | 145.13 | -59.46 | 153.64 | 56.47 | |||||
Dividend Per Share, 1 Yr. Growth % | - | - | - | - | - | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 11.88 | -6.22 | 12.66 | 33.11 | 8.29 | |||||
Gross Profit, 2 Yr. CAGR % | 20.53 | 1.89 | 12.31 | 34.31 | 19.05 | |||||
EBITDA, 2 Yr. CAGR % | 42.28 | -10.44 | 21.15 | 58.32 | 7.37 | |||||
EBITA, 2 Yr. CAGR % | 52.33 | -17.44 | 21.71 | 72.87 | 6.17 | |||||
EBIT, 2 Yr. CAGR % | 53.18 | -17.23 | 21.75 | 72.87 | 6.17 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 14.46 | -35.57 | 24.74 | 90.91 | -22.56 | |||||
Net Income, 2 Yr. CAGR % | 27.85 | -24.67 | 8.65 | 70.68 | -69.71 | |||||
Normalized Net Income, 2 Yr. CAGR % | 20.07 | -6.91 | 24.74 | 30.93 | -29.31 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 6.12 | -29.2 | 31.1 | 71 | -69.72 | |||||
Accounts Receivable, 2 Yr. CAGR % | 24.63 | 12.13 | 4.99 | 4.18 | -2.89 | |||||
Inventory, 2 Yr. CAGR % | -17.95 | 34.33 | 55 | 50.08 | 78.55 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 9.28 | 7.45 | 8 | 13.2 | 15.15 | |||||
Total Assets, 2 Yr. CAGR % | 9.74 | 25.99 | 29.03 | 23.14 | 34.46 | |||||
Tangible Book Value, 2 Yr. CAGR % | 34.58 | 35.88 | 9.42 | 0.46 | 6.78 | |||||
Common Equity, 2 Yr. CAGR % | 31.74 | 31.83 | 10.96 | 2.81 | 5.96 | |||||
Cash From Operations, 2 Yr. CAGR % | -51.7 | -26.86 | 111.66 | 156.13 | 56.19 | |||||
Capital Expenditures, 2 Yr. CAGR % | -10.47 | 30.02 | 16.21 | 5.97 | 51.19 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -28.47 | 283.9 | 3.27 | 3.6 | 86.74 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -38.37 | 143.31 | -0.04 | -1.4 | 99.22 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | - | - | - | - | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 11.6 | 1.62 | 9.93 | 14.37 | 20.79 | |||||
Gross Profit, 3 Yr. CAGR % | 15.75 | 7.6 | 14.84 | 16.6 | 26.72 | |||||
EBITDA, 3 Yr. CAGR % | 18.08 | 11.26 | 19.2 | 22.4 | 31.31 | |||||
EBITA, 3 Yr. CAGR % | 19.43 | 10.79 | 18.87 | 24.36 | 37.4 | |||||
EBIT, 3 Yr. CAGR % | 19.71 | 11.23 | 19.08 | 24.4 | 37.4 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 11.41 | -7 | 1.87 | 30.59 | 15.15 | |||||
Net Income, 3 Yr. CAGR % | 29.13 | -0.32 | 3.51 | 20.74 | -43.62 | |||||
Normalized Net Income, 3 Yr. CAGR % | 19.88 | 14.44 | 8.98 | 21.31 | -9.28 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 16.47 | -0.3 | -0.56 | 36.84 | -43.56 | |||||
Accounts Receivable, 3 Yr. CAGR % | 5.86 | 12.52 | 14.74 | -0.14 | 4.25 | |||||
Inventory, 3 Yr. CAGR % | -13.54 | 9.05 | 31.06 | 63.08 | 58.44 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 9.08 | 8.72 | 7.77 | 11.29 | 12.86 | |||||
Total Assets, 3 Yr. CAGR % | 10.37 | 19.5 | 23.06 | 29.08 | 28.51 | |||||
Tangible Book Value, 3 Yr. CAGR % | 24.09 | 34.77 | 17.83 | 10.89 | 0.34 | |||||
Common Equity, 3 Yr. CAGR % | 21.89 | 31.33 | 17.92 | 11.32 | 1.94 | |||||
Cash From Operations, 3 Yr. CAGR % | -11.55 | -26.76 | 12.29 | 124.06 | 85.41 | |||||
Capital Expenditures, 3 Yr. CAGR % | 11.13 | 15.5 | 5.9 | 28.74 | 17.56 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 133.88 | 5.98 | 93.36 | 32.87 | 17.71 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 122.04 | 0.4 | 34.13 | 33.82 | 15.01 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | - | - | - | - | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 4.84 | 5.35 | 11.97 | 13.31 | 9.27 | |||||
Gross Profit, 5 Yr. CAGR % | 13.33 | 10.32 | 14.18 | 17.96 | 16.51 | |||||
EBITDA, 5 Yr. CAGR % | 16.65 | 8.9 | 18.78 | 29.44 | 13.83 | |||||
EBITA, 5 Yr. CAGR % | 16.75 | 6.75 | 19.73 | 34.2 | 13.62 | |||||
EBIT, 5 Yr. CAGR % | 16.73 | 6.98 | 19.92 | 34.51 | 13.74 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 1.51 | 3.82 | 16.68 | 24.01 | -8.71 | |||||
Net Income, 5 Yr. CAGR % | 6.53 | 15.79 | 20.58 | 23.61 | -36.69 | |||||
Normalized Net Income, 5 Yr. CAGR % | 15.94 | 34.08 | 21.75 | 20.76 | -8.35 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -1.25 | 17.03 | 22.22 | 23.71 | -38.2 | |||||
Accounts Receivable, 5 Yr. CAGR % | 7.8 | 3.51 | 5.5 | 9.11 | 7.33 | |||||
Inventory, 5 Yr. CAGR % | -9.54 | 5.07 | 9.2 | 23.91 | 48.32 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 10.78 | 7.85 | 8.64 | 10.49 | 10.67 | |||||
Total Assets, 5 Yr. CAGR % | 8.66 | 15.22 | 17.47 | 20.94 | 27.49 | |||||
Tangible Book Value, 5 Yr. CAGR % | 13.47 | 22.83 | 18.01 | 19.82 | 13.28 | |||||
Common Equity, 5 Yr. CAGR % | 12.39 | 20.27 | 17.4 | 19.08 | 12.98 | |||||
Cash From Operations, 5 Yr. CAGR % | -17.8 | 27.29 | 25.27 | 21.16 | 28.13 | |||||
Capital Expenditures, 5 Yr. CAGR % | -4.78 | 15.28 | 13.13 | 11.33 | 22.11 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -4.86 | 42.36 | 70.95 | 5.13 | 89.07 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -8.34 | 48.85 | 64.08 | -0.21 | 55.38 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | - | - | - | - |
- Stock Market
- Equities
- GODREJIND Stock
- Financials Godrej Industries Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition